These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 19684186)

  • 1. Pharmacological stimulation of soluble guanylate cyclase modulates hypoxia-inducible factor-1alpha in rat heart.
    Tsuruda T; Hatakeyama K; Masuyama H; Sekita Y; Imamura T; Asada Y; Kitamura K
    Am J Physiol Heart Circ Physiol; 2009 Oct; 297(4):H1274-80. PubMed ID: 19684186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stimulation of cGMP signalling protects coronary endothelium against reperfusion-induced intercellular gap formation.
    Kasseckert SA; Schäfer C; Kluger A; Gligorievski D; Tillmann J; Schlüter KD; Noll T; Sauer H; Piper HM; Abdallah Y
    Cardiovasc Res; 2009 Jul; 83(2):381-7. PubMed ID: 19234300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pressure-overload-induced subcellular relocalization/oxidation of soluble guanylyl cyclase in the heart modulates enzyme stimulation.
    Tsai EJ; Liu Y; Koitabashi N; Bedja D; Danner T; Jasmin JF; Lisanti MP; Friebe A; Takimoto E; Kass DA
    Circ Res; 2012 Jan; 110(2):295-303. PubMed ID: 22095726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Feedback control through cGMP-dependent protein kinase contributes to differential regulation and compartmentation of cGMP in rat cardiac myocytes.
    Castro LR; Schittl J; Fischmeister R
    Circ Res; 2010 Nov; 107(10):1232-40. PubMed ID: 20847310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NO-independent stimulation or activation of soluble guanylyl cyclase during early reperfusion limits infarct size.
    Bice JS; Keim Y; Stasch JP; Baxter GF
    Cardiovasc Res; 2014 Feb; 101(2):220-8. PubMed ID: 24259501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cinaciguat, a novel activator of soluble guanylate cyclase, protects against ischemia/reperfusion injury: role of hydrogen sulfide.
    Salloum FN; Das A; Samidurai A; Hoke NN; Chau VQ; Ockaili RA; Stasch JP; Kukreja RC
    Am J Physiol Heart Circ Physiol; 2012 Mar; 302(6):H1347-54. PubMed ID: 22268103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nitric oxide-independent stimulation of soluble guanylate cyclase with BAY 41-2272 in cardiovascular disease.
    Boerrigter G; Burnett JC
    Cardiovasc Drug Rev; 2007; 25(1):30-45. PubMed ID: 17445086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Soluble guanylyl cyclase activation improves progressive cardiac remodeling and failure after myocardial infarction. Cardioprotection over ACE inhibition.
    Fraccarollo D; Galuppo P; Motschenbacher S; Ruetten H; Schäfer A; Bauersachs J
    Basic Res Cardiol; 2014 Jul; 109(4):421. PubMed ID: 24907870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HNO/cGMP-dependent antihypertrophic actions of isopropylamine-NONOate in neonatal rat cardiomyocytes: potential therapeutic advantages of HNO over NO.
    Irvine JC; Cao N; Gossain S; Alexander AE; Love JE; Qin C; Horowitz JD; Kemp-Harper BK; Ritchie RH
    Am J Physiol Heart Circ Physiol; 2013 Aug; 305(3):H365-77. PubMed ID: 23729209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced vascular responses to soluble guanylyl cyclase but increased sensitivity to sildenafil in female rats with type 2 diabetes.
    Goulopoulou S; Hannan JL; Matsumoto T; Ogbi S; Ergul A; Webb RC
    Am J Physiol Heart Circ Physiol; 2015 Jul; 309(2):H297-304. PubMed ID: 25957216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the relaxant effect of the nitric oxide-independent soluble guanylyl cyclase stimulator BAY 41-2272 in isolated detrusor smooth muscle.
    Báu FR; Mónica FZ; Priviero FB; Baldissera L; de Nucci G; Antunes E
    Eur J Pharmacol; 2010 Jul; 637(1-3):171-7. PubMed ID: 20399768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preconditioning with soluble guanylate cyclase activation prevents postischemic inflammation and reduces nitrate tolerance in heme oxygenase-1 knockout mice.
    Wang WZ; Jones AW; Wang M; Durante W; Korthuis RJ
    Am J Physiol Heart Circ Physiol; 2013 Aug; 305(4):H521-32. PubMed ID: 23771693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The soluble guanylate cyclase stimulator riociguat and the soluble guanylate cyclase activator cinaciguat exert no direct effects on contractility and relaxation of cardiac myocytes from normal rats.
    Reinke Y; Gross S; Eckerle LG; Hertrich I; Busch M; Busch R; Riad A; Rauch BH; Stasch JP; Dörr M; Felix SB
    Eur J Pharmacol; 2015 Nov; 767():1-9. PubMed ID: 26407652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms of relaxant activity of the nitric oxide-independent soluble guanylyl cyclase stimulator BAY 41-2272 in rat tracheal smooth muscle.
    Toque HA; Mónica FZ; Morganti RP; De Nucci G; Antunes E
    Eur J Pharmacol; 2010 Oct; 645(1-3):158-64. PubMed ID: 20670622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Different influences of extracellular and intracellular superoxide on relaxation through the NO/sGC/cGMP pathway in isolated rat iliac arteries.
    Tawa M; Shimosato T; Iwasaki H; Imamura T; Okamura T
    J Cardiovasc Pharmacol; 2015 Feb; 65(2):160-7. PubMed ID: 25329747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The soluble guanylate cyclase stimulator BAY 41-2272 inhibits vascular smooth muscle growth through the cAMP-dependent protein kinase and cGMP-dependent protein kinase pathways.
    Joshi CN; Martin DN; Fox JC; Mendelev NN; Brown TA; Tulis DA
    J Pharmacol Exp Ther; 2011 Nov; 339(2):394-402. PubMed ID: 21825001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of VASP phosphorylation in cardiac myocytes: differential regulation by cyclic nucleotides and modulation of protein expression in diabetic and hypertrophic heart.
    Sartoretto JL; Jin BY; Bauer M; Gertler FB; Liao R; Michel T
    Am J Physiol Heart Circ Physiol; 2009 Nov; 297(5):H1697-710. PubMed ID: 19734360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pressure-independent effects of pharmacological stimulation of soluble guanylate cyclase on fibrosis in pressure-overloaded rat heart.
    Masuyama H; Tsuruda T; Sekita Y; Hatakeyama K; Imamura T; Kato J; Asada Y; Stasch JP; Kitamura K
    Hypertens Res; 2009 Jul; 32(7):597-603. PubMed ID: 19424280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The soluble guanylyl cyclase activator bay 58-2667 selectively limits cardiomyocyte hypertrophy.
    Irvine JC; Ganthavee V; Love JE; Alexander AE; Horowitz JD; Stasch JP; Kemp-Harper BK; Ritchie RH
    PLoS One; 2012; 7(11):e44481. PubMed ID: 23144773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nitric oxide stimulates human sperm motility via activation of the cyclic GMP/protein kinase G signaling pathway.
    Miraglia E; De Angelis F; Gazzano E; Hassanpour H; Bertagna A; Aldieri E; Revelli A; Ghigo D
    Reproduction; 2011 Jan; 141(1):47-54. PubMed ID: 20965947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.